US approves high-dose opioid reversal nasal spray from Hikma
US approves high-dose opioid reversal nasal spray from Hikma The Food and Drug Administration approved Hikma Pharmaceuticals' Kloxxado, a spray containing 8 milligrams of naloxone - double the highest dose currently available. https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment